CN102964416A - 用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 - Google Patents
用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 Download PDFInfo
- Publication number
- CN102964416A CN102964416A CN2012105267715A CN201210526771A CN102964416A CN 102964416 A CN102964416 A CN 102964416A CN 2012105267715 A CN2012105267715 A CN 2012105267715A CN 201210526771 A CN201210526771 A CN 201210526771A CN 102964416 A CN102964416 A CN 102964416A
- Authority
- CN
- China
- Prior art keywords
- crystallization
- add
- content
- dryings
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960001091 chenodeoxycholic acid Drugs 0.000 title claims abstract description 32
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 title claims abstract description 31
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 title abstract 3
- 238000002425 crystallisation Methods 0.000 claims description 72
- 230000008025 crystallization Effects 0.000 claims description 72
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- 238000001291 vacuum drying Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 21
- 241000283690 Bos taurus Species 0.000 claims description 16
- 241001494479 Pecora Species 0.000 claims description 16
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 15
- 239000003613 bile acid Substances 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- 229960001661 ursodiol Drugs 0.000 claims description 14
- DLYVTEULDNMQAR-SRNOMOOLSA-N Cholic Acid Methyl Ester Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCC(=O)OC)[C@@]2(C)[C@@H](O)C1 DLYVTEULDNMQAR-SRNOMOOLSA-N 0.000 claims description 12
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 9
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 9
- 239000003208 petroleum Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 239000001632 sodium acetate Substances 0.000 claims description 7
- 229960004249 sodium acetate Drugs 0.000 claims description 7
- 235000017281 sodium acetate Nutrition 0.000 claims description 7
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 7
- 239000001117 sulphuric acid Substances 0.000 claims description 7
- 235000011149 sulphuric acid Nutrition 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 230000003252 repetitive effect Effects 0.000 claims description 6
- 238000005201 scrubbing Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004380 Cholic acid Substances 0.000 abstract description 4
- 229960002471 cholic acid Drugs 0.000 abstract description 4
- 235000019416 cholic acid Nutrition 0.000 abstract description 4
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 abstract description 4
- -1 chenodeoxycholic acid compound Chemical class 0.000 abstract description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract description 3
- ZXKXJHAOUFHNAS-FVGYRXGTSA-N (S)-fenfluramine hydrochloride Chemical compound [Cl-].CC[NH2+][C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 ZXKXJHAOUFHNAS-FVGYRXGTSA-N 0.000 abstract 1
- 241000271566 Aves Species 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 125000003907 chenodeoxycholic acid group Chemical group 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000006154 Chronic hepatitis C Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105267715A CN102964416A (zh) | 2012-12-10 | 2012-12-10 | 用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105267715A CN102964416A (zh) | 2012-12-10 | 2012-12-10 | 用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102964416A true CN102964416A (zh) | 2013-03-13 |
Family
ID=47794875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012105267715A Pending CN102964416A (zh) | 2012-12-10 | 2012-12-10 | 用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102964416A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139399A (ja) * | 1983-01-31 | 1984-08-10 | Showa Denko Kk | ウルソデオキシコ−ル酸の製造方法 |
JP2004307390A (ja) * | 2003-04-07 | 2004-11-04 | Mitsubishi Chemicals Corp | ステロイド化合物の製造方法 |
CN1850846A (zh) * | 2006-05-23 | 2006-10-25 | 辽宁百隆生物工程有限公司 | 用鸡胆提取鹅去氧胆酸的生产方法 |
CN101215311A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用含量86%的鹅去氧胆酸生产熊去氧胆酸的生产方法 |
CN101215309A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用98%的牛羊胆酸生产鹅去氧胆酸的生产方法 |
CN101215310A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用含量为98.0%牛羊胆酸生产熊去氧胆酸的生产方法 |
ES2318927A1 (es) * | 2005-08-25 | 2009-05-01 | Universidade De Santiago De Compostela | Nuevos dimeros de acidos biliares funcionalizados en la posicion 24 de la cadena alquilica de la sal biliar. procedimientos para su obtencion y aplicaciones. |
-
2012
- 2012-12-10 CN CN2012105267715A patent/CN102964416A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139399A (ja) * | 1983-01-31 | 1984-08-10 | Showa Denko Kk | ウルソデオキシコ−ル酸の製造方法 |
JP2004307390A (ja) * | 2003-04-07 | 2004-11-04 | Mitsubishi Chemicals Corp | ステロイド化合物の製造方法 |
ES2318927A1 (es) * | 2005-08-25 | 2009-05-01 | Universidade De Santiago De Compostela | Nuevos dimeros de acidos biliares funcionalizados en la posicion 24 de la cadena alquilica de la sal biliar. procedimientos para su obtencion y aplicaciones. |
CN1850846A (zh) * | 2006-05-23 | 2006-10-25 | 辽宁百隆生物工程有限公司 | 用鸡胆提取鹅去氧胆酸的生产方法 |
CN101215311A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用含量86%的鹅去氧胆酸生产熊去氧胆酸的生产方法 |
CN101215309A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用98%的牛羊胆酸生产鹅去氧胆酸的生产方法 |
CN101215310A (zh) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | 用含量为98.0%牛羊胆酸生产熊去氧胆酸的生产方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101215310A (zh) | 用含量为98.0%牛羊胆酸生产熊去氧胆酸的生产方法 | |
FI65440C (fi) | Foerfarande foer separering av beta-sitosterol med en laog alfa-sitosterolhalt | |
CN108218943B (zh) | 将鸡胆中的鹅去氧胆酸和胆酸合成熊去氧胆酸的方法 | |
CN101987860A (zh) | 一种熊去氧胆酸的制备方法 | |
CN110256517B (zh) | 一种从猪胆汁或下脚料中生产高纯度鹅去氧胆酸的方法 | |
CN110790805A (zh) | 一种从猪胆膏中提取鹅去氧胆酸的方法 | |
CN101830956A (zh) | 猪胆膏或下脚料中鹅去氧胆酸的分离纯化制备方法 | |
CN102827234A (zh) | 一种从鸭胆汁中分离提纯鹅去氧胆酸的方法 | |
CN101215311B (zh) | 用含量86%的鹅去氧胆酸生产熊去氧胆酸的生产方法 | |
CN101215309A (zh) | 用98%的牛羊胆酸生产鹅去氧胆酸的生产方法 | |
CN103113447A (zh) | 钙盐法提取鸭胆汁中鹅去氧胆酸 | |
EP1903050B1 (en) | A process for the preparation of cholanic acids | |
CN103012532A (zh) | 用含量98.5%的牛羊胆酸生产熊去氧胆酸的生产方法 | |
CN105481927B (zh) | 一种从鸭胆汁中提取鸭胆酸和鹅去氧胆酸的方法 | |
CN102964416A (zh) | 用含量为98.5%的牛羊胆酸生产鹅去氧胆酸的生产方法 | |
CN103992263B (zh) | 一种多奈哌齐的纯化方法 | |
CN104119414A (zh) | 高质量黄体酮的制备方法 | |
CN103012539B (zh) | 用含量98.5%的熊去氧胆酸生产牛磺熊去氧胆酸的生产方法 | |
CN111285915A (zh) | 一种从禽类苦胆中提取及精制鹅去氧胆酸的新型工艺 | |
CN105646635B (zh) | 从鸡胆提取工业废液中回收胆酸方法 | |
CN108440521B (zh) | 一种利用黄藤素生产盐析废液制备黄藤素的方法 | |
CN100368419C (zh) | 一种工业化生产盐酸克林霉素棕榈酸酯的方法 | |
CN108299538B (zh) | 一种清除鸭胆汁中异熊去氧胆酸的方法 | |
CN109593812A (zh) | 一种酶促法合成3-酮基脱氧胆酸的方法 | |
US2108646A (en) | Sterine derivatives and process of preparing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIAONING BAILONG BIOENGINEERING CO., LTD. Free format text: FORMER OWNER: LIAONING BAIFENG BIOLOGY PHARMACEUTICAL CO., LTD. Effective date: 20130410 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 117004 BENXI, LIAONING PROVINCE TO: 110122 SHENYANG, LIAONING PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130410 Address after: 110122, No. two, No. 24 South Road, Shitai economic and Technological Development Zone, Shenyang, Liaoning Applicant after: Liaoning Bailong Bioengineering Co., Ltd. Applicant after: Liu Mohan Address before: 117004, Liaoning, Benxi Province, Lake District, stone bridge, spring Ann street, No. 5 Applicant before: LIAONING BAIFENG BIO-PHARMACEUTICAL CO., LTD. Applicant before: Liaoning Bailong Bioengineering Co., Ltd. Applicant before: Liu Mohan |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130313 |